参考文献/References:
[1] 郭妍妍, 刘雅娟, 王琳, 等. 功能化高分子脂质体包裹的纳米金颗粒作为新型CT造影剂的初步研究[J]. 中国生化药物杂志, 2017, 37 (4):5-8. DOI:10.3969/j.issn.1005-1678.2017.04.002. Guo YY, Liu YJ, Wang L, et al. Preliminary research on functional polymer liposome-entrapped gold nanoparticles as CT contrast agents[J]. Chin J Biological Pharms, 2017, 37 (4):5-8.
[2] Rajkumar S, Prabaharan M. Theranostics Based on Iron Oxide and Gold Nanoparticles for Imaging-Guided Photothermal and Photodynamic Therapy of Cancer[J]. Curr Top Med Chem, 2017, 17 (16):1858-1871. DOI:10.2174/1568026617666161122120537
[3] Liu Y, Ai K, Lu L. Nanoparticulate X-ray computed tomography contrast agents:from design validation to in vivo applications[J]. Acc Chem Res, 2012, 45 (10):1817-1827. DOI:10.1021/ar300150c.
[4] Lin W, Zhang X, Qian L, et al. Doxorubicin-Loaded Unimolecular Micelle-Stabilized Gold Nanoparticles as a Theranostic Nanoplatform for Tumor-Targeted Chemotherapy and Computed Tomography Imaging[J]. Biomacromolecules, 2017, 18 (12):3869-3880. DOI:10.1021/acs.biomac.7b00810.
[5] Sasidharan S, Bahadur D, Srivastava R. Albumin stabilized gold nanostars:A biocompatible nanoplatform for SERS, CT imaging and photothermal therapy of cancer[J]. Rsc Advances, 2016, 6 (87):84025-84034. DOI:10.1039/C6RA11405A.
[6] 翟宏菊, 戴晓威, 曹爽, 等. 金纳米粒子的合成、性质及其应用新进展[J]. 吉林师范大学学报 (自然科学版), 2017, 38 (2):13-16. DOI:10.16862/j.cnki.issn1674-3873.2017.02.003. Zhai HJ, Dai XW, Cao S. New Progress of Synthesis, Properties and Applications of Gold Nanoparticles[J]. J Jilin Normal Univ (Natural Science Edition), 2017, 38 (2):13-16.
[7] 余建明. 实用医学影像技术[M]. 人民卫生出版社, 2015:501. Yu JM. Practical medical imaging technology[M]. People’s health press, 2015:501.
[8] Beik J, Jafariyan M, Montazerabadi A, et al. The benefits of folic acid-modified gold nanoparticles in CT-based molecular imaging:radiation dose reduction and image contrast enhancement[J/OL]. Artif Cells Nanomed Biotechnol, 2017:1-9[2018-01-05]. https://www.ncbi.nlm.nih.gov/pubmed/29233015. DOI:10.1080/21691401. 2017. 1408019.
[9] Seibert JA, Boone JM. X-ray imaging physics for nuclear medicine technologists. Part 2:X-ray interactions and image formatio[J]. J Nucl Med Technol, 2005, 33 (1):3-18.
[10] Kang S, Eom J, Kim B, et al. Evaluation of gold K-edge imaging using spectral computed tomography with a photon-counting detector:A Monte Carlo simulation study[J]. Optik-Inter J Light Electron Optics, 2017, 140:253-260. DOI:10.1016/j.ijleo.2017.04. 062.
[11] 李锋坦, 李东, 张云亭. 管电压对CT值测量、辐射剂量及图像质量影响的模型研究[J]. 中华放射学杂志, 2013, 47 (5):458-461. DOI:10.3760/cma.j.issn.1005-1201.2013.05.016. Li FT, Li D, Zhang YT. Influence of tube voltage on CT attenuation, radiation dose, and image quality:phantom study[J]. Chin J Radiol, 2013, 47 (5):458-461.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[9]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[10]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]